Atlas Trials

12 Week Study of Anti-Viral Effect of Oral UT-231B in Non-cirrhotic Hepatitis C Patients who have Failed Interferon-based Therapy.

Clinical trial NCT00069511 · UNKNOWN

Trial details

NCT number
NCT00069511
Sponsor
United Therapeutics
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Hepatitis C
Start date
2003-07-01
Enrollment
72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.